Your browser doesn't support javascript.
loading
Study protocol: BRInging the Diabetes prevention program to GEriatric Populations.
Beasley, Jeannette M; Johnston, Emily A; Sevick, Mary Ann; Jay, Melanie; Rogers, Erin S; Zhong, Hua; Zabar, Sondra; Goldberg, Eric; Chodosh, Joshua.
Afiliação
  • Beasley JM; Department of Nutrition and Food Studies, New York University, New York, NY, United States.
  • Johnston EA; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States.
  • Sevick MA; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States.
  • Jay M; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States.
  • Rogers ES; Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States.
  • Zhong H; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States.
  • Zabar S; Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States.
  • Goldberg E; VA New York Harbor Healthcare System, Medicine Service, New York, NY, United States.
  • Chodosh J; Department of Population Health, Institute for Excellence in Health Equity, New York University, New York, NY, United States.
Front Med (Lausanne) ; 10: 1144156, 2023.
Article em En | MEDLINE | ID: mdl-37275370
ABSTRACT
In the Diabetes Prevention Program (DPP) randomized, controlled clinical trial, participants who were ≥ 60 years of age in the intensive lifestyle (diet and physical activity) intervention had a 71% reduction in incident diabetes over the 3-year trial. However, few of the 26.4 million American adults age ≥65 years with prediabetes are participating in the National DPP. The BRInging the Diabetes prevention program to GEriatric Populations (BRIDGE) randomized trial compares an in-person DPP program Tailored for Older AdulTs (DPP-TOAT) to a DPP-TOAT delivered via group virtual sessions (V-DPP-TOAT) in a randomized, controlled trial design (N = 230). Eligible patients are recruited through electronic health records (EHRs) and randomized to the DPP-TOAT or V-DPP-TOAT arm. The primary effectiveness outcome is 6-month weight loss and the primary implementation outcome is intervention session attendance with a non-inferiority design. Findings will inform best practices in the delivery of an evidence-based intervention.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article